List of bibliographic references
Number of relevant bibliographic references: 7.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 5 | Parkinson disease |
| 3 | Animal |
| 3 | Animal model |
| 3 | D2 Dopamine receptor |
| 3 | D3 Dopamine receptor |
| 3 | Dopamine |
| 3 | Dyskinesia |
| 3 | Levodopa |
| 3 | Treatment |
| 2 | Acute |
| 2 | Animals |
| 2 | Antiparkinson Agents (pharmacology) |
| 2 | Autoradiography |
| 2 | Corpus Striatum (drug effects) |
| 2 | Corpus striatum |
| 2 | Levodopa (pharmacology) |
| 2 | Locus niger |
| 2 | Monkey |
| 2 | Mouse |
| 2 | Nervous system diseases |
| 2 | Rotigotine |
| 1 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 1 | Abnormal movement |
| 1 | Agonist |
| 1 | Antiparkinson Agents (administration & dosage) |
| 1 | Antiparkinson Agents (adverse effects) |
| 1 | Carrier protein |
| 1 | Cells, Cultured |
| 1 | Chronic |
| 1 | Clinical trial |
| 1 | Comparative study |
| 1 | Corpus Striatum (metabolism) |
| 1 | Corpus Striatum (pathology) |
| 1 | Corpus Striatum (physiopathology) |
| 1 | D1 Dopamine receptor |
| 1 | Degeneration |
| 1 | Development |
| 1 | Dopamine Plasma Membrane Transport Proteins (metabolism) |
| 1 | Dopamine agonist |
| 1 | Dyskinesia, Drug-Induced (physiopathology) |
| 1 | Dyskinesia, Drug-Induced (therapy) |
| 1 | Encephalon |
| 1 | Enkephalin |
| 1 | Enkephalins (metabolism) |
| 1 | Ex vivo |
| 1 | Experimental data |
| 1 | Experimental study |
| 1 | Female |
| 1 | Functional Laterality |
| 1 | Gene Expression (drug effects) |
| 1 | Genetic Therapy |
| 1 | Histone |
| 1 | Human |
| 1 | Involuntary movement |
| 1 | Lesion |
| 1 | Levodopa (administration & dosage) |
| 1 | Levodopa (adverse effects) |
| 1 | Macaca mulatta |
| 1 | Male |
| 1 | Mimic |
| 1 | Models |
| 1 | Modification |
| 1 | Motor control |
| 1 | Neuroprotection |
| 1 | Neurotoxin |
| 1 | Oligonucleotides, Antisense (administration & dosage) |
| 1 | Opioid peptide |
| 1 | Opioid receptor |
| 1 | Oxidopamine |
| 1 | Parkinson Disease, Secondary (etiology) |
| 1 | Parkinson Disease, Secondary (metabolism) |
| 1 | Parkinson Disease, Secondary (prevention & control) |
| 1 | Parkinsonian Disorders (drug therapy) |
| 1 | Parkinsonian Disorders (physiopathology) |
| 1 | Photon |
| 1 | Precursor |
| 1 | Prevention |
| 1 | Protein Binding (drug effects) |
| 1 | Protein Precursors (metabolism) |
| 1 | RGS Proteins (genetics) |
| 1 | RGS Proteins (metabolism) |
| 1 | RNA, Messenger (metabolism) |
| 1 | Rats, Sprague-Dawley |
| 1 | Ropinirole |
| 1 | Single photon emission tomography |
| 1 | Tomography, Emission-Computed, Single-Photon (methods) |
| 1 | Toxicity |
| 1 | Up-Regulation (drug effects) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Paula Ravenscroft"
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i \
-Sk "Paula Ravenscroft" \
| HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= UK
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Paula Ravenscroft
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
